Works matching DE "AVATROMBOPAG"

Results: 58

Correction to: Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia.

Published in:: Gastroenterology Report, 2023, v. 11, p. 1, doi. 10.1093/gastro/goac086
Publication type:: Article

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia.

Published in:

Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goac059

By:

Biolato, Marco;
Vitale, Federica;
Marrone, Giuseppe;
Miele, Luca;
Grieco, Antonio

Publication type:

Article

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.

Published in:

Journal of Blood Medicine, 2019, v. 11, p. 313, doi. 10.2147/JBM.S191790

By:

Cheloff, Abraham Z;
Al-Samkari, Hanny

Publication type:

Article

Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis.

Published in:

Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221105976

By:

Lu, Jun;
Jamieson, Brian D.;
Hui, Ai-Min

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 188, doi. 10.1002/cpdd.349

By:

Nomoto, Maiko;
Pastino, Gina;
Rege, Bhaskar;
Aluri, Jagadeesh;
Ferry, Jim;
Han, David

Publication type:

Article

Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1393829

By:

Ting Zhang;
Qingling Yu;
Xiaoyu Chen;
Hui Yang;
Yuemin Gong;
Yawen Zhang;
Xiaoqing Liu;
Zhinan Yang;
Yu Fang;
Xue Yan;
Xuan Zhou;
Jinning Shi;
Guangsheng He

Publication type:

Article

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2224044

By:

Wan, Ziqi;
Chen, Miao;
Han, Bing

Publication type:

Article

Long‐term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real‐world observational study.

Published in:

British Journal of Haematology, 2025, v. 206, n. 3, p. 935, doi. 10.1111/bjh.19973

By:

Wang, Nan;
Wang, Zhifa;
Liu, Jingjing;
Hu, Yu;
Dong, Shuyue;
Chen, Hui;
Meng, Jinxi;
Ma, Jingyao;
Chen, Zhenping;
Cheng, Xiaoling;
Wu, Runhui

Publication type:

Article

Avatrombopag in adults with immune thrombocytopenia: A multicentre real‐life observational study in Madrid, Spain (AVAMAD study).

Published in:

British Journal of Haematology, 2025, v. 206, n. 2, p. 652, doi. 10.1111/bjh.19975

By:

Pascual‐Izquierdo, Cristina;
Llacer‐Ferrandis, Mª. Jose;
de‐la‐Iglesia, Almudena;
Monsalvo‐Saornil, Silvia;
Menor‐Gómez, María;
Gil‐Fernández, Juan Jose;
Chica‐Gullon, Esther;
Álvarez‐Román, María Teresa;
Perez‐Segura, Gloria;
Zafra, Denis;
Ortuzar‐Pasalodos, Ariana;
González‐Gascón‐y‐Marín, Isabel Teresa;
Moreno, Gemma;
Arquero‐Portero, Teresa;
Moreno‐Carbonell, Marta;
Revilla, Nuria

Publication type:

Article

Avatrombopag for the treatment of patients with chemotherapy‐induced thrombocytopenia: A case series.

Published in:

British Journal of Haematology, 2025, v. 206, n. 1, p. 272, doi. 10.1111/bjh.19797

By:

Galamaga, Robert;
Johnston, Stephanie;
Acosta, Cassaundra

Publication type:

Article

A second chance for avatrombopag in chemotherapy‐induced thrombocytopenia.

Published in:

British Journal of Haematology, 2025, v. 206, n. 1, p. 375, doi. 10.1111/bjh.19861

By:

Al‐Samkari, Hanny;
Moore, Donald C.

Publication type:

Article

Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Published in:

British Journal of Haematology, 2024, v. 205, n. 6, p. 2414, doi. 10.1111/bjh.19800

By:

Tian, Hong;
Zhou, Lu;
Dai, Jia‐wen;
Li, Yun;
Gu, Cheng‐Yuan;
Kong, Dan‐Qing;
Yu, Zi‐Qiang;
Liu, Xiao‐fan;
Yin, Jie

Publication type:

Article

Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Published in:

British Journal of Haematology, 2024, v. 205, n. 6, p. 2414, doi. 10.1111/bjh.19800

By:

Tian, Hong;
Zhou, Lu;
Dai, Jia‐wen;
Li, Yun;
Gu, Cheng‐Yuan;
Kong, Dan‐Qing;
Yu, Zi‐Qiang;
Liu, Xiao‐fan;
Yin, Jie

Publication type:

Article

Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia.

Published in:

British Journal of Haematology, 2024, v. 205, n. 4, p. 1551, doi. 10.1111/bjh.19602

By:

Mingot‐Castellano, Maria Eva;
Bastida, Jose Maria;
Ghanima, Waleed;
Ruiz Sainz, Elena;
Nuñez Vazquez, Ramiro;
Pedrote Amador, Begoña;
Abdel‐Kader Martín, Laila;
Piquer‐Monsonis, Dolores;
Canaro, Mariana

Publication type:

Article

Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China.

Published in:

British Journal of Haematology, 2024, v. 204, n. 5, p. 1958, doi. 10.1111/bjh.19342

By:

Wang, Zhifa;
Zhang, Aijun;
Xu, Zhongjin;
Wang, Nan;
Zhang, Jialu;
Meng, Jinxi;
Dong, Shuyue;
Ma, Jingyao;
Hu, Yu;
Ouyang, Juntao;
Chen, Zhenping;
An, Qi;
Cheng, Xiaoling;
Wu, Runhui

Publication type:

Article

A phase 3, randomized, double‐blind, active‐controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 897, doi. 10.1111/bjh.18908

By:

Tarantino, Michael D.;
Bussel, James B.;
Lee, Eun‐Ju;
Jamieson, Brian D.

Publication type:

Article

Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 890, doi. 10.1111/bjh.18897

By:

Bussel, James B.;
Tarantino, Michael D.;
Lee, Eun‐Ju;
Jamieson, Brian D.

Publication type:

Article

Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real‐world study in China.

Published in:

British Journal of Haematology, 2023, v. 202, n. 3, p. 636, doi. 10.1111/bjh.18864

By:

Cheng, Xiaoling;
Wang, Zhifa;
Dong, Shuyue;
Ma, Jingyao;
Meng, Jinxi;
Wang, Xiaoling;
Wu, Runhui

Publication type:

Article

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.

Published in:

British Journal of Haematology, 2022, v. 197, n. 3, p. 359, doi. 10.1111/bjh.18081

By:

Al‐Samkari, Hanny;
Jiang, Debbie;
Gernsheimer, Terry;
Liebman, Howard;
Lee, Susie;
Wojdyla, Matthew;
Vredenburg, Michael;
Cuker, Adam

Publication type:

Article

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.

Published in:

Annals of Hematology, 2023, v. 102, n. 4, p. 715, doi. 10.1007/s00277-023-05114-8

By:

Pulanić, Dražen;
Bátorová, Angelika;
Bodó, Imre;
Červinek, Libor;
Ionita, Ioana;
Lissitchkov, Toshko;
Melikyan, Anahit;
Podolak-Dawidziak, Maria

Publication type:

Article

Safety of non-peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta-analysis of short-term double-blind randomized clinical trials.

Published in:

Experimental & Therapeutic Medicine, 2023, v. 26, n. 2, p. 1, doi. 10.3892/etm.2023.12092

By:

NAN SHEN;
JIBING QIAO;
YAZHOU JIANG;
HANJUN YIN;
MIN LI;
SUYUE ZHU;
JIANQIN LI

Publication type:

Article

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.

Published in:

Biomedical Reports, 2024, v. 20, n. 3, p. N.PAG, doi. 10.3892/br.2024.1732

By:

Shen, Nan;
Qiao, Jibing;
Jiang, Yazhou;
Yan, Jingjing;
Wu, Rang;
Yin, Hanjun;
Zhu, Suyue;
Li, Jianqin

Publication type:

Article

Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report.

Published in:

Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1253230

By:

Weikang Meng;
Jinsheng Hua;
Jiabing Wang

Publication type:

Article

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives.

Published in:

Therapeutics & Clinical Risk Management, 2022, v. 18, p. 273, doi. 10.2147/TCRM.S251672

By:

Tsykunova, Galina;
Ghanima, Waleed

Publication type:

Article

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2023.2195016

By:

Jain, Shivi;
Gernsheimer, Terry;
Kolodny, Scott;
Bernheisel, Chelsea;
Vredenburg, Michael;
Panch, Sandhya R.

Publication type:

Article

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2023.2195016

By:

Jain, Shivi;
Gernsheimer, Terry;
Kolodny, Scott;
Bernheisel, Chelsea;
Vredenburg, Michael;
Panch, Sandhya R.

Publication type:

Article

Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.

Published in:

2022

By:

Arif, Abdul Rehman;
Zhao, Miaomiao;
Chen, Wenlan;
Xue, Mei;
Luo, Shanshan;
Wang, Yadan

Publication type:

Case Study

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.

Published in:

Platelets, 2022, v. 33, n. 7, p. 1024, doi. 10.1080/09537104.2022.2026910

By:

Gao, Yanting;
Liu, Qi;
Shen, Yingying;
Li, Yuzhu;
Shao, Keding;
Ye, Baodong;
Shen, Yiping;
Zhou, Yuhong;
Wu, Dijiong

Publication type:

Article

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension.

Published in:

Platelets, 2022, v. 33, n. 2, p. 257, doi. 10.1080/09537104.2021.1881952

By:

Al‐Samkari, Hanny;
Nagalla, Srikanth

Publication type:

Article

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.

Published in:

2023

By:

Abdelsamia, Mahmoud;
Farid, Saira;
Dean, Steven;
Cataland, Spero R.

Publication type:

Case Study

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1009612

By:

Yong-Shuai Wang;
Wei Wang;
Sai Zhang;
Shen-Yu Zhang;
Ai-Zong Shen;
Hua-Chuan Song;
Huan-Zhang Yao;
Rui-Peng Song;
Fan-Zheng Meng;
Lei Li;
Nashan, Bjoern;
Ji-Zhou Wang;
Lian-Xin Liu

Publication type:

Article

Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.970978

By:

Yayun Cui;
Yifu He;
Changlu Hu;
Congyin Tu;
Jin Huang;
Xiaofeng Zhu;
Chunbao Zang;
Kaiyang Ding;
Bihong Zhan;
Yufei Zhao;
Liting Qian

Publication type:

Article

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1576053

By:

Sau, Antonella;
Di Prinzio, Gianfranco;
Onofrillo, Daniela;
Russo, Anna Caterina;
Santoro, Nicole;
Di Ianni, Mauro

Publication type:

Article

Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.

Published in:

International Journal of Hepatology, 2020, p. 1, doi. 10.1155/2020/5421632

By:

Poordad, Fred;
Terrault, Norah A.;
Alkhouri, Naim;
Tian, Wei;
Allen, Lee F.;
Rabinovitz, Mordechai

Publication type:

Article

The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence.

Published in:

International Journal of Hepatology, 2016, p. 1, doi. 10.1155/2016/1802932

By:

Qureshi, Kamran;
Patel, Shyam;
Meillier, Andrew

Publication type:

Article

Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.

Published in:

2022

By:

Jiang, Ziming;
Jiang, Xianyong;
Chen, Miao

Publication type:

Letter

Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis.

Published in:

Annals of Hematology, 2022, v. 101, n. 5, p. 953, doi. 10.1007/s00277-022-04784-0

By:

Zhou, Huifeng;
Fan, Junjie;
He, Jie;
Hu, Shaoyan

Publication type:

Article

Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US food and drug administration's adverse event reporting system.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62129-5

By:

Zhu, Hong;
Wu, Meng

Publication type:

Article

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia.

Published in:

2022

By:

Tu, Xiaofang;
Xue, Ali;
Wu, Suye;
Jin, Mengmeng;
Zhao, Pu;
Zhang, Hao

Publication type:

Case Study

Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 952, doi. 10.1111/bcp.13517

By:

Nomoto, Maiko;
Zamora, Cynthia A.;
Schuck, Edgar;
Boyd, Peter;
Chang, Min‐Kun;
Aluri, Jagadeesh;
Siu, Y. Amy;
Lai, W. George;
Yasuda, Sanae;
Ferry, Jim;
Rege, Bhaskar

Publication type:

Article

Avatrombopag, an oral thrombopoietin receptor agonist: results of two double‐blind, dose‐rising, placebo‐controlled Phase 1 studies.

Published in:

British Journal of Haematology, 2018, v. 183, n. 3, p. 466, doi. 10.1111/bjh.15574

By:

Kuter, David J.;
Allen, Lee F.

Publication type:

Article

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.

Published in:

British Journal of Haematology, 2018, v. 183, n. 3, p. 479, doi. 10.1111/bjh.15573

By:

Jurczak, Wojciech;
Chojnowski, Krzysztof;
Mayer, Jiří;
Krawczyk, Katarzyna;
Jamieson, Brian D.;
Tian, Wei;
Allen, Lee F.

Publication type:

Article

Avatrombopag.

Published in:

British Journal of Haematology, 2018, v. 183, n. 3, p. 342, doi. 10.1111/bjh.15568

By:

Bussel, James B.

Publication type:

Article

Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.

Published in:

2018

By:

Al‐Samkari, Hanny;
Kuter, David J.

Publication type:

Case Study

An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia.

Published in:

Expert Review of Clinical Immunology, 2022, v. 18, n. 8, p. 783, doi. 10.1080/1744666X.2022.2098119

By:

Song, Andrew B.;
Al‐Samkari, Hanny

Publication type:

Article

Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00829

By:

Li, Chunlu;
Li, Xiaoxuan;
Huang, Feihong;
Yang, Jing;
Wu, Anguo;
Wang, Long;
Qin, Dalian;
Zou, Wenjun;
Wu, Jianming

Publication type:

Article

Avatrombopag for the Treatment of Immune Thrombocytopenia.

Published in:

European Journal of Haematology, 2025, v. 114, n. 5, p. 733, doi. 10.1111/ejh.14395

By:

Labanca, Caterina;
Vigna, Ernesto;
Martino, Enrica Antonia;
Bruzzese, Antonella;
Mendicino, Francesco;
Caridà, Giulio;
Lucia, Eugenio;
Olivito, Virginia;
Puccio, Noemi;
Neri, Antonino;
Morabito, Fortunato;
Gentile, Massimo

Publication type:

Article

Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Study.

Published in:

Acta Haematologica, 2023, v. 146, n. 3, p. 173, doi. 10.1159/000528642

By:

Liu, Yin;
Zhang, Han-Xi;
Su, Juan;
Geng, Qing-Chao;
Lin, Xin;
Feng, Chen-Xi

Publication type:

Article

Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03659-8

By:

Hu, Huan;
Lei, Dongmei;
Liang, Yan

Publication type:

Article

Avatrombopag Effectively Maintained Platelet Counts in a Patient with Immune Thrombocytopenia Who Was Intolerant to Tyrosine Kinase Inhibitor Therapy.

Published in:

2021

By:

Maitland, Hillary S.

Publication type:

Case Study